Radiation Therapy Oncology Group (RTOG) 92-02 [60] trial included 1554 patients with locally advanced prostate cancer treated for 4 months with radiotherapy and GnRH agonist followed or not by 24 months of adjuvant GnRH agonist. Here, GNRH1 is linked to prostate carcinoma.